Kitamura and team (113) linked higher IL11 protein levels with Nrf2 expression in human breast cancer and found that Keap1-null MEFs in three-dimensional culture elevate Il11, which crucially impacts tumor engraftment and is reduced by Il11 knockout. Here, IL11 is linked to breast carcinoma.